For research use only. Not for therapeutic Use.
Ginsenoside Rh1（Cat No.:I004382）is a bioactive compound derived from Panax ginseng, known for its wide range of pharmacological effects. It plays a significant role in enhancing immune function, reducing inflammation, and exhibiting antioxidant properties. Studies show that Ginsenoside Rh1 may support cognitive function, protect against oxidative stress, and improve skin health. Additionally, it has potential applications in cancer research due to its ability to inhibit tumor cell proliferation. This compound is valuable in pharmaceutical research for its diverse therapeutic potential and health benefits.
| Catalog Number | I004382 |
| CAS Number | 63223-86-9 |
| Molecular Formula | C36H62O9 |
| Purity | ≥95% |
| Target | Vitamin D Related/Nuclear Receptor |
| Solubility | 10 mM in DMSO |
| Storage | Store at -20°C |
| IUPAC Name | (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| InChI | InChI=1S/C36H62O9/c1-19(2)10-9-13-36(8,43)20-11-15-34(6)26(20)21(38)16-24-33(5)14-12-25(39)32(3,4)30(33)22(17-35(24,34)7)44-31-29(42)28(41)27(40)23(18-37)45-31/h10,20-31,37-43H,9,11-18H2,1-8H3/t20-,21+,22-,23+,24+,25-,26-,27+,28-,29+,30-,31+,33+,34+,35+,36-/m0/s1 |
| InChIKey | RAQNTCRNSXYLAH-RFCGZQMISA-N |
| SMILES | CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O)C |
| Reference | <p style=/line-height:25px/> <br>[2]. Feng Y, et al. Ginsenoside Rh1 Improves the Effect of Dexamethasone on Autoantibodies Production and Lymphoproliferation in MRL/lpr Mice. Evid Based Complement Alternat Med. 2015;2015:727650. <br>[3]. Siddiqi MH, et al. Ginsenoside Rh1 induces mouse osteoblast growth and differentiation through the bone morphogenetic protein 2/runt-related gene 2 signalling pathway. J Pharm Pharmacol. 2014 Dec;66(12):1763-73. <br>[4]. Fayeza M. Siraj, et al. In silico screening of ginsenoside Rh1 with PPARγ and in vitro analysis on 3T3-L1 cell line. Molecular Simulation </p> |
